Rosuvastatin Tablet, Film Coated
Product Images NDC 50090-7240

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 50090-7240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 1)

This is a statistical data showing comparison of respiratory syncytial virus (RSV) and placebo treatments on a group of individuals over time. RSV treatment had 8901 individuals at the beginning and 8412 individuals at the end of the study, followed by a breakdown of individuals at various intervals. The placebo group started with 8901 individuals, and had 8353 individuals at end of the study, with a similar breakdown of individuals at various intervals. The data also includes confidence intervals and statistical significance levels.*

FDA Label Image

Figure-02 (Figure 2)

This text presents data comparing the effect of Rosuva 20 mg and Placebo 20 mg on different cardiovascular events. The study includes details such as the number of events for each endpoint, the Hazard Ratio (HR) with confidence intervals and p-values. Key endpoints evaluated include the primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. The data provides insights into the effectiveness of Rosuva compared to placebo in reducing cardiovascular events.*

FDA Label Image

Figure-02 (Figure 3)

FDA Label Image

Label Image (Lbl500907240)

FDA Label Image

Structural Formula (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.